Pharmacological abortion in out-patient practice


Cite item

Full Text

Abstract

Data for the pharmacological properties of mifepristone and misoprostol - the most effective drugs used for medical abortion as an alternative to surgical intervention are presented. Author considers international experience on the use of mifepristone and misoprostol, and provides recommendations for their use to induce abortion in the I trimester of pregnancy. According to a study conducted in Research Center of Obstetrics, Gynecology and Perinatology, the effectiveness of mifepristone and misoprostol combination was 98%. The results of the study indicate that the use of combination of antigestagen mifepristone and prostaglandin E1 misoprostol is a highly effective method of pregnancy termination. In full compliance with all necessary requirements this method is well tolerated in women and can be used to early pregnancy termination.

About the authors

A A Kuzemin

A Kuzemin

References

  1. Кулаков В.И Планирование семьи в России: идеология и стратегия // Планирование семьи. 1997. № 1. С. 12-13.
  2. Вихляева Е.М., Савельева И.С., Городничева Ж.А. Возможности клинического применения антипрогестинов в акушерстве и гинекологии // Вопросы гинекологии, акушерства и перинатологии. № 6. 2007. С. 1-11.
  3. Липман А.Д., Левина И.С., Кочев Д.М. Использование мифепристона для медикаментозного прерывания беременности и других целей // Сибирский медицинский журнал. 2002. № 4. С. 46-62.
  4. Манушарова Р.А., Черкезова Э.И. Медикаментозное прерывание малых сроков беременности // Лечащий врач. 2004. № 2.
  5. Разрешение ФС по надзору в сфере здравоохранения и соц. развития на применение новой медицинской технологии «Медикаментозный аборт на ранних сроках беременности» ФС№2009/339 от 16.10.2009.
  6. Aubeny E, Chatellier G. A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. Eur J Contracept Reprod Health Care 2000;5:171-6.
  7. Aubeny E, Peyron R, Tuprin CL, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995;40(Suppl 2):85-91.
  8. Brogden RN, Goa KL, Faulds D. Mifepristone: a review of its pharmacodynamic and pharmacokinetics properties and therapeutic potencial. Drug 1993;45;384-409/
  9. Heikinheimo O. Clinical pharmacokinetics of mifepristone. Clin Pharmakokinet 1997;33:7-17.
  10. McDonnel DP. Unraveling the human progesterone receptor signal yransduction pathways (insight into antiprogestin action). Trends Endocrinol Metab 1995;6:133-8.
  11. Peyron R, Aubeny E, Tarzus V, et al. Early termination of pregnancy with mifepristone (RU486) and orally active prostaglandin misoprostol. N Engl J Med 1993, 328, 1509-1513.
  12. Refaey H, Rajasclar D, Abdalla M, Calcler L, Templeton A. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 1995;332:983-7.
  13. Robbins A, Spitz IM. Mifepristone: clinical pharmacology. Clin Obstet Gynecol 1996;39:436-50.
  14. Schaff EA, Eisinger SH, Stadalius LS, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion . Fam Pract 1997;44:353-60.
  15. Spitz I M, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and the orally active prostaglandin misoprostol. N Engl J Med 1998;176:1241-7.
  16. Spitz M, Bardin C.W. Mifepristone (RU486) - a modulator ofprogestin and antiglucocorticoid action N Engl J Med 1993;329:404-12.
  17. Spitz M, Croxatto HB, Robbins A. Antiprogestin: mechanism of action and contraceptive potential. Ann Rev Pharmacol Toxicol 1996;36:47-81.
  18. Urquhart DR, Templeton AA, Shinewi F. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation: UK Multicentre Study - Final Results. Contraception 1997;55:1-5.
  19. WHO. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 2000;107:524-30.
  20. WHO. Pregnancy termination with mifepristone and gemeprost: a multicentre comparison between repeated doses and a single dose of mifepristone. Fertil Sferil 1991;56:32-40.
  21. WHO. Termination of pregnancy with reduced doses mifepristone. BMJ 1993;307:532-537
  22. Winikoff B, Sivin I, Coyaji KJ, Caberaz E, et al. The acceptability of medical abortion in China, Cuba and India. Int Fam Plan Perspect 1997;23:73-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies